Finch Therapeutics

Finch throws in the towel on microbiome journey, lets go of 77 employees
Endpoints
Tue, 01/24/23 - 10:23 am
Finch Therapeutics
layoffs
microbiome
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
layoffs
Cyclerion
OncoSec
Exicure
AbbVie
Bristol Myers Squibb
Palisade Bio
ObsEva
Rubius Therapeutics
Novartis
Finch Therapeutics
One week after Takeda walked away, Finch faces second round of layoffs, pipeline pruning
Endpoints
Thu, 09/1/22 - 10:45 am
Finch Therapeutics
Takeda
layoffs
C. difficile
Finch Therapeutics Regains Rights to Two Takeda-Owned IBD Drugs
BioSpace
Fri, 08/26/22 - 10:41 am
Takeda
Finch Therapeutics
FIN-524
FIN-525
inflammatory bowel disease
FDA lifts hold on Finch’s microbiome crapsule, as company looks to right ship
Endpoints
Fri, 04/29/22 - 10:34 am
Finch Therapeutics
FDA
microbiome
crapsules
clinical trials
C. difficile
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism
Fierce Biotech
Fri, 04/1/22 - 10:38 am
Finch Therapeutics
hepatitis B
microbiome
clinical trials
autism
C. difficile
FDA slaps hold on Finch's C. diff med to get info on COVID-19 screening for donor-derived therapy
Fierce Biotech
Thu, 03/3/22 - 10:21 am
Finch Therapeutics
C. difficile
clinical hold
FDA
clinical trials
microbiome
The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
Endpoints
Fri, 03/19/21 - 11:22 am
IPOs
NASDAQ
Instil Bio
Connect Biopharma
Finch Therapeutics
Gain Therapeutics
Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street
Endpoints
Mon, 03/1/21 - 11:42 pm
IPOs
SPAC
Finch Therapeutics
microbiome
Connect Biopharma
Insil Bio
Transcode Therapeutics
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline
Xconomy
Thu, 09/17/20 - 10:42 am
microbiome
Finch Therapeutics
Seres Therapeutics
In big year for microbiome drugs, a small biotech sets the bar
BioPharma Dive
Fri, 06/19/20 - 11:22 am
biotech
microbiome
Finch Therapeutics
C. difficile
Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease
Endpoints
Wed, 11/13/19 - 11:22 pm
Takeda
Finch Therapeutics
microbiome
Crohn's Disease
Microbiome Report
CP Wire
Thu, 08/29/19 - 11:43 pm
microbiome
Finch Therapeutics
Scioto Biosciences
Microbiome Report
Thu, 08/29/19 - 11:18 pm
microbiome
Finch Therapeutics
Scioto Biosciences
Microbiome company Finch raises $53M ahead of anti-infective readout
BioCentury
Fri, 08/23/19 - 09:51 am
microbiome
Finch Therapeutics
C. difficile
Investigational Live Microbial Drug Granted Breakthrough Therapy Designation for Recurrent C. Difficile
CP Wire
Fri, 02/8/19 - 09:42 am
Finch Therapeutics
CP101
C. difficile
microbiome
Investigational Live Microbial Drug Granted Breakthrough Therapy Designation for Recurrent C. Difficile
Fri, 02/8/19 - 09:37 am
Finch Therapeutics
CP101
C. difficile
microbiome
Microbiome Report for the week ending 7-29-18
CP Wire
Wed, 08/1/18 - 11:49 pm
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Microbiome Report for the week ending 7-29-18
Wed, 08/1/18 - 11:48 pm
microbiome
Finch Therapeutics
patents
Qu Biologics
Crohn’s disease
Alzheimer's disease
Finch Therapeutics Expands Microbiome IP Portfolio with Six New Patents
CP Wire
Wed, 07/25/18 - 09:43 am
Finch Therapeutics
microbiome
patents

Pages